- Non-vaccination Against COVID-19 Among Venezuelan Refugees and Migrants Adults in Peru: A Cross-sectional Study, 2022
-
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández
-
J Prev Med Public Health. 2023;56(5):397-406. Published online August 17, 2023
-
DOI: https://doi.org/10.3961/jpmph.23.078
-
-
 Abstract
Summary
 PDF
- Objectives
The purpose of this study was to determine factors associated with non-vaccination against coronavirus disease 2019 (COVID-19) among the Venezuelan immigrant population residing in Peru.
Methods
A cross-sectional study was conducted using data obtained from the Second Survey of the Venezuelan Population Residing in Peru in 2022. The dependent variable was vaccination status against COVID-19. The independent variables included socio-demographic, economic, and migratory characteristics of the included population. Crude and adjusted generalized linear Poisson-family models were used to calculate prevalence ratios with 95% confidence intervals (CIs).
Results
A total of 7739 Venezuelan migrants aged 18 years or older were included. The proportion of non-vaccination against COVID-19 was 5.7%. Regarding associated factors, unemployment (adjusted prevalence ratio [aPR], 1.31; 95% CI, 1.04 to 1.65) was linked to an increased likelihood of not being vaccinated against COVID-19. In contrast, women (aPR, 0.76; 95% CI, 0.61 to 0.95), possessing a migration permit (aPR, 0.41; 95% CI, 0.31 to 0.54), and having health insurance (aPR, 0.47; 95% CI, 0.27 to 0.81) were associated with a decreased likelihood of being unvaccinated.
Conclusions
The primary governmental and non-governmental institutions responsible for supporting and protecting the Venezuelan migrant and refugee population should improve vaccination access by issuing migration permits and providing health insurance.
-
Summary
Key Message
• Vaccination against COVID-19 is a strategy that should be provided equitably to the entire population. However, there are vulnerable groups such as Venezuelan migrants who have structural, cultural and socioeconomic barriers that limit access to this prevention system.
• In Peru, about 6% of Venezuelan migrants have not received the complete vaccination schedule against COVID-19 due to the lack of employment in this population. In fact, the majority (61.9%) of Venezuelan migrants have only received two doses of the COVID-19 vaccine by February 2022.
- Socio-demographic Determinants of Low Physical Activity in Peruvian Adults: Results of a Population-based Survey Performed in 2017-2018
-
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández
-
J Prev Med Public Health. 2021;54(6):461-470. Published online November 7, 2021
-
DOI: https://doi.org/10.3961/jpmph.21.418
-
-
3,767
View
-
100
Download
-
4
Web of Science
-
4
Crossref
-
Abstract
PDF
- Objectives
The objective of this study was to determine the prevalence of low physical activity (PA) in Peruvian adults and to identify associated factors.
Methods
An analytical study was performed using data from the 2017-2018 Nutritional Food Surveillance by Life Stages survey. The outcome variable was low PA (yes or no), assessed using the International Physical Activity Questionnaire-short form. Prevalence ratios were estimated as a measure of association.
Results
Among the 1045 persons included in the analysis, the age-standardized prevalence of low PA was 61.9%. The adjusted model showed that being female and migrating from a rural to an urban area in the last 5 years were associated with a higher probability of having low PA than males and individuals who had not migrated, while residing in rural highlands and jungle areas was associated with a reduced probability of having low PA compared to people residing in other geographic domains.
Conclusions
Being a female and migration from a rural to an urban area in the last 5 years were associated with a higher likelihood of having low PA. Therefore, promotion and prevention strategies related to PA are required, especially in the female and migrant populations.
-
Summary
-
Citations
Citations to this article as recorded by  - Lifestyle Factors, Sociodemographic Characteristics and Incident Hypertension: A Prospective Analysis of the Korean National Health Insurance Service Sample Cohort
Jung-Eun Lee, Anthony Kityo, Sang-Ah Lee
Journal of Personalized Medicine.2024; 14(9): 959. CrossRef - Individualized Biological Age as a Predictor of Disease: Korean Genome and Epidemiology Study (KoGES) Cohort
Seokyung An, Choonghyun Ahn, Sungji Moon, Eun Ji Sim, Sue-Kyung Park
Journal of Personalized Medicine.2022; 12(3): 505. CrossRef - Association between Altitude and the Framingham Risk Score: A Cross-Sectional Study in the Peruvian Adult Population
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández, Manuel Chacón-Diaz
International Journal of Environmental Research and Public Health.2022; 19(7): 3838. CrossRef - Prevalence of Prehypertension and Associated Cardiovascular Risk Profiles among Adults in Peru: Findings from a Nationwide Population-Based Study
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández
International Journal of Environmental Research and Public Health.2022; 19(13): 7867. CrossRef
- Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study
-
Akram Hernández-Vásquez, Diego Azañedo, Rodrigo Vargas-Fernández, Guido Bendezu-Quispe
-
J Prev Med Public Health. 2020;53(4):211-219. Published online May 28, 2020
-
DOI: https://doi.org/10.3961/jpmph.20.186
-
-
8,959
View
-
2,342
Download
-
24
Crossref
-
Abstract
PDF
- Objectives
The goal of this study was to identify chronic conditions and multimorbidity patterns in patients with coronavirus disease 2019 (COVID-19) and to examine their associations with pneumonia and death.
Methods
This cross-sectional study analyzed the official data of COVID-19 patients in Mexico through May 18, 2020 (released by the Secretaría de Salud de México). Adjusted logistic regression models were applied to assess the associations of comorbidities with pneumonia and death. The marginal effects were estimated, and the probability of pneumonia or death according to the number of comorbidities was graphed for each year of age.
Results
Of the 51 053 COVID-19 patients enrolled in the final analysis, 27 667 (54.2%) had no chronic conditions, while 13 652 (26.7%), 6518 (12.8%) and 3216 (6.3%) were reported to have 1, 2, and 3 or more simultaneous conditions, respectively. Overall, a significant incremental gradient was observed for the association between multimorbidity and pneumonia (p<0.001); for 2 chronic conditions, the adjusted odds ratio (aOR) was 2.07 (95% confidence interval [CI], 1.95 to 2.20), and for ≥3 conditions, the aOR was 2.40 (95% CI, 2.22 to 2.60). A significant incremental gradient was also found for the relationship between multimorbidity and death (p<0.001); an aOR of 2.51 (95% CI, 2.30 to 2.73) was found for 2 chronic conditions and an aOR of 3.49 (95% CI, 3.15 to 3.86) for ≥3 conditions.
Conclusions
Underlying chronic conditions and multimorbidity are associated with pneumonia and death in Mexican COVID-19 patients. Future investigation is necessary to clarify the pathophysiological processes behind this association, given the high burden of chronic diseases in various countries, including Mexico.
-
Summary
-
Citations
Citations to this article as recorded by - A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization
Gilberto González-Parra, Javier Villanueva-Oller, F.J. Navarro-González, Josu Ceberio, Giulia Luebben
Chaos, Solitons & Fractals.2024; 181: 114695. CrossRef - Impact of COVID-19 on ‘Start Smart, Then Focus’ Antimicrobial Stewardship at One NHS Foundation Trust in England Prior to and during the Pandemic
Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
COVID.2024; 4(1): 102. CrossRef - Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
Tatjana T. Makovski, Jinane Ghattas, Stéphanie Monnier-Besnard, Lisa Cavillot, Monika Ambrožová, Barbora Vašinová, Rodrigo Feteira-Santos, Peter Bezzegh, Felipe Ponce Bollmann, James Cottam, Romana Haneef, Brecht Devleesschauwer, Niko Speybroeck, Paulo Jo
Aging Clinical and Experimental Research.2024;[Epub] CrossRef - Mortalidad en adultos mexicanos de 50 a 80 años de edad con multimorbilidad en un período de observación de 18 años
Beatriz Novak, Daniel Lozano Keymolen
Estudios Demográficos y Urbanos.2023; 38(1): 9. CrossRef - Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination
Lenin Domínguez-Ramírez, Francisca Sosa-Jurado, Guadalupe Díaz-Sampayo, Itzel Solis-Tejeda, Francisco Rodríguez-Pérez, Rosana Pelayo, Gerardo Santos-López, Paulina Cortes-Hernandez
Vaccines.2023; 11(11): 1676. CrossRef - Study of optimal vaccination strategies for early COVID-19 pandemic using an age-structured mathematical model: A case study of the USA
Giulia Luebben, Gilberto González-Parra, Bishop Cervantes
Mathematical Biosciences and Engineering.2023; 20(6): 10828. CrossRef - HEMOGRAM INDICATORS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY COVID-19 DEPENDING ON THE CHARLSON COMORBIDITY INDEX
T. M. Homeliuk, M. I. Marushchak
Bulletin of Problems Biology and Medicine.2023; 1(1): 161. CrossRef - Correlates of In-Hospital COVID-19 Deaths: A Competing Risks Survival Time Analysis of Retrospective Mortality Data
Ashish Goel, Alpana Raizada, Ananya Agrawal, Kamakshi Bansal, Saurabh Uniyal, Pratima Prasad, Anil Yadav, Asha Tyagi, RS Rautela
Disaster Medicine and Public Health Preparedness.2022; 16(5): 1889. CrossRef - Inference on the Beta Type I Generalized Half Logistic Distribution under Right-Censored Observation with Application to COVID-19
Phillip Oluwatobi Awodutire, Ethelbert Chinaka Nduka, Maxwell Azubike Ijomah, Oluwatosin Ruth Ilori, Oluwafemi Samson Balogun, Niansheng Tang
International Journal of Mathematics and Mathematical Sciences.2022; 2022: 1. CrossRef - Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis
Jacqueline Betsabe Puicón-Suárez, Sandra Zeña-Ñañez, Virgilio E. Failoc-Rojas
PeerJ.2022; 10: e13437. CrossRef - The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment
Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, Keyao Yu, Ming Hu, Dongming Jiang, Guangwen Cao
Journal of Hypertension.2022; 40(12): 2323. CrossRef - Associations of symptom combinations with in-hospital mortality of coronavirus disease-2019 patients using South Korean National data
Suyoung Jo, Hee-kyoung Nam, Heewon Kang, Sung-il Cho, Russell Kabir
PLOS ONE.2022; 17(8): e0273654. CrossRef - Epidemiological Profile and Social Welfare Index as Factors Associated with COVID-19 Hospitalization and Severity in Mexico City: A Retrospective Analysis
Mario Antonio Téllez-González, Juan Antonio Pineda-Juárez, Juan Antonio Suárez-Cuenca, Mónica Escamilla-Tilch, Daniel Santillán-Cortez, Silvia García, Sofía Lizeth Alcaraz-Estrada, Juan Carlos Pérez-Razo, Carlos Alberto Delgado-Quintana, Joel Vargas-Herná
International Journal of Environmental Research and Public Health.2022; 19(22): 14803. CrossRef - Trends of COVID-19 Admissions in an Italian Hub during the Pandemic Peak: Large Retrospective Study Focused on Older Subjects
Andrea Ticinesi, Antonio Nouvenne, Nicoletta Cerundolo, Alberto Parise, Beatrice Prati, Angela Guerra, Tiziana Meschi
Journal of Clinical Medicine.2021; 10(5): 1115. CrossRef - Ethnic disparities in COVID-19 mortality in Mexico: A cross-sectional study based on national data
Ismael Ibarra-Nava, Kathia G. Flores-Rodriguez, Violeta Ruiz-Herrera, Hilda C. Ochoa-Bayona, Alfonso Salinas-Zertuche, Magaly Padilla-Orozco, Raul G. Salazar-Montalvo, Mary Hamer Hodges
PLOS ONE.2021; 16(3): e0239168. CrossRef - Association of Kidney Disease With Outcomes in COVID‐19: Results From the American Heart Association COVID‐19 Cardiovascular Disease Registry
Anjali Rao, Sagar Ranka, Colby Ayers, Nicholas Hendren, Anna Rosenblatt, Heather M. Alger, Christine Rutan, Wally Omar, Rohan Khera, Kamal Gupta, Purav Mody, Christopher DeFilippi, Sandeep R. Das, S. Susan Hedayati, James A. de Lemos
Journal of the American Heart Association.2021;[Epub] CrossRef - Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico
Francisco Javier García-Alvarado, Melisa Alejandra Muñoz-Hernández, Elida Moran Guel, Marisela del Rocío González-Martínez, Maritza Argelia Macías Corral, Héctor Alberto Delgado-Aguirre
Vector-Borne and Zoonotic Diseases.2021; 21(9): 720. CrossRef - COVID‐19‐related deaths among women of reproductive age in Brazil: The burden of postpartum
Roxana Knobel, Maíra L. S. Takemoto, Marcos Nakamura‐Pereira, Mariane O. Menezes, Vicente K. Borges, Leila Katz, Melania M. R. Amorim, Carla B. Andreucci
International Journal of Gynecology & Obstetrics.2021; 155(1): 101. CrossRef - Autosomal Dominant Polycystic Kidney Disease Does Not Significantly Alter Major COVID-19 Outcomes among Veterans
Xiangqin Cui, Julia W. Gallini, Christine L. Jasien, Michal Mrug
Kidney360.2021; 2(6): 983. CrossRef - The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates
Hongjie Hou, Jie Xu, Yang Li, Yadong Wang, Haiyan Yang
The Journal of Allergy and Clinical Immunology: In Practice.2021; 9(11): 3944. CrossRef - Factors Associated With Severe COVID-19 Infection Among Persons of Different Ages Living in a Defined Midwestern US Population
Jennifer L. St. Sauver, Guilherme S. Lopes, Walter A. Rocca, Kavita Prasad, Michelle R. Majerus, Andrew H. Limper, Debra J. Jacobson, Chun Fan, Robert M. Jacobson, Lila J. Rutten, Aaron D. Norman, Celine M. Vachon
Mayo Clinic Proceedings.2021; 96(10): 2528. CrossRef - Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat-Saleh, Thibault Fiolet, Mathieu Edouard Rebeaud, Matthieu Mulot, Anthony Guihur, Douae El Fatouhi, Nasser Laouali, Nathan Peiffer-Smadja, Dagfinn Aune, Gianluca Severi
BMJ Open.2021; 11(10): e052777. CrossRef - Stability, Bifurcation, and a Pair of Conserved Quantities in a Simple Epidemic System with Reinfection for the Spread of Diseases Caused by Coronaviruses
Jorge Fernando Camacho, Cruz Vargas-De-León, Hassan A. El Morshedy
Discrete Dynamics in Nature and Society.2021; 2021: 1. CrossRef - Evaluation of Treatment Outcome for Pneumonia among Pre-Vaccinated COVID-19 Patients with/without Comorbidity in a Public Hospital in Bengkulu, Indonesia
Diana Laila Ramatillah, Siew Hua Gan, Syed Azhar Syed Sulaiman, Dama Puja, Usman Abubakar, Ammar Ali Saleh Jaber, Stefanus Lukas, Nina Jusnita
Vaccines.2021; 9(12): 1411. CrossRef
- Measuring Out-of-pocket Payment, Catastrophic Health Expenditure and the Related Socioeconomic Inequality in Peru: A Comparison Between 2008 and 2017
-
Akram Hernández-Vásquez, Carlos Rojas-Roque, Rodrigo Vargas-Fernández, Diego Rosselli
-
J Prev Med Public Health. 2020;53(4):266-274. Published online June 10, 2020
-
DOI: https://doi.org/10.3961/jpmph.20.035
-
-
5,117
View
-
196
Download
-
10
Crossref
-
Abstract
PDF
 Supplementary Material
- Objectives
Describe out-of-pocket payment (OOP) and the proportion of Peruvian households with catastrophic health expenditure (CHE) and evaluate changes in socioeconomic inequalities in CHE between 2008 and 2017.
Methods
We used data from the 2008 and 2017 National Household Surveys on Living and Poverty Conditions (ENAHO in Spanish), which are based on probabilistic stratified, multistage and independent sampling of areas. OOP was converted into constant dollars of 2017. A household with CHE was assumed when the proportion between OOP and payment capacity was ≥0.40. OOP was described by median and interquartile range while CHE was described by weighted proportions and 95% confidence intervals (CIs). To estimate the socioeconomic inequality in CHE we computed the Erreygers concentration index.
Results
The median OOP reduced from 205.8 US dollars to 158.7 US dollars between 2008 and 2017. The proportion of CHE decreased from 4.9% (95% CI, 4.5 to 5.2) in 2008 to 3.7% (95% CI, 3.4 to 4.0) in 2017. Comparison of socioeconomic inequality of CHE showed no differences between 2008 and 2017, except for rural households in which CHE was less concentrated in richer households (p<0.05) and in households located on the rest of the coast, showing an increase in the concentration of CHE in richer households (p<0.05).
Conclusions
Although OOP and CHE reduced between 2008 and 2017, there is still socioeconomic inequality in the burden of CHE across different subpopulations. To reverse this situation, access to health resources and health services should be promoted and guaranteed to all populations.
-
Summary
-
Citations
Citations to this article as recorded by - Causes of death among international travellers in Peru, 2017 to 2021
Kasim Allel, Miguel M Cabada, Collen Lau, Deborah Mills, Richard C Franklin, Yan Zhu, Luis Furuya-Kanamori
Journal of Travel Medicine.2024;[Epub] CrossRef - Informal payments in health facilities in Peru in 2018: Analysis of a cross-sectional survey
Laura Espinoza-Pajuelo, Patricia Mallma, Hannah Hogan Leslie, Patricia Jannet García, Sarthak Gaurav
PLOS Global Public Health.2024; 4(1): e0001837. CrossRef - An Examination of Inter-State Variation in Utilization of Healthcare Services, Associated Financial Burden and Inequality: Evidence from Nationally Representative Survey in India
Aashima, Rajesh Sharma
International Journal of Social Determinants of Health and Health Services.2024; 54(3): 206. CrossRef - Prevalence and Determinants of Catastrophic Healthcare Expenditures in Iran From 2013 to 2019
Abdoreza mousavi, Farhad lotfi, Samira Alipour, Aliakbar Fazaeli, Mohsen Bayati
Journal of Preventive Medicine and Public Health.2024; 57(1): 65. CrossRef - Consumer Financial Protection Versus Catastrophic Healthcare Expenditure in Zambia
MccPowell Fombang, Richard Wamalwa Wanzala
Public Health Challenges.2024;[Epub] CrossRef - Cost-sharing and associated factors in the Peruvian private health care system
Luciana Bellido-Boza, David Villarreal-Zegarra, Max Pariona-Cárdenas, Roger Carrión, Paul Valdivia-Miranda, G. J. Melendez-Torres, Oriana Rivera-Lozada de Bonilla
PLOS ONE.2024; 19(8): e0308277. CrossRef - High cost drugs in Latin America: access and barriers
Diego Rosselli
Expert Review of Pharmacoeconomics & Outcomes Research.2023; 23(6): 619. CrossRef - Determinants of Eye Care Service Utilization among Peruvian Adults: Evidence from a Nationwide Household Survey
Antonio Barrenechea-Pulache, Andres Portocarrero-Bonifaz, Akram Hernández-Vásquez, Carlos Portocarrero-Ramos, Jenny Moscoso-Carrasco
Ophthalmic Epidemiology.2022; 29(3): 339. CrossRef - Financial risk protection from out-of-pocket health spending in low- and middle-income countries: a scoping review of the literature
Taslima Rahman, Dominic Gasbarro, Khurshid Alam
Health Research Policy and Systems.2022;[Epub] CrossRef - THE IGNORED PANDEMIC OF PUBLIC HEALTH CORRUPTION: A CALL FOR ACTION AMID AND BEYOND SARS-COV-2/COVID-19
Jorge A. Sánchez-Duque, Zhaohui Su, Diego Rosselli, Maria Camila Chica-Ocampo, Maria Isabel Lotero-Puentes, Ana M. Bolaños-Portilla, Manish Dhawan, Alfonso J. Rodríguez-Morales, Kuldeep Dhama
Journal of Experimental Biology and Agricultural Sciences.2021; 9(2): 108. CrossRef
|
KSPM
